Nicotine inhibits cytokine production by placenta cells via NFκB: Potential role in pregnancy-induced hypertension

Molecular Medicine

Volumn 13, Issue 11-12, 2007, Pages 576-583

  Dowling, Oonagh ^a   Rochelson, Burton ^b   Way, Kathleen ^a   Al Abed, Yousef ^a   Metz, Christine N ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR; CAP 55; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CYTOKINE; FIBROBLAST GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NICOTINE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; VASCULAR DISEASE;

BASE SEQUENCE; CYTOKINES; DNA PRIMERS; FEMALE; HUMANS; HYPERTENSION; LIPOPOLYSACCHARIDES; NF-KAPPA B; NICOTINE; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; RECEPTORS, NICOTINIC;

EID: 36849073794     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2007-00067.Dowling     Document Type: Article

References (71)

1. Klonoff-Cohen H, Edelstein A Savitz D. (1993) Cigarette smoking and preeclampsia. Obstet. Gynecol. 81:541-4.
2. Marcoux S, Brisson J, Fabia J. (1989) The effect of cigarette smoking on the risk of preeclampsia and gestational hypertension. Am. J. Epidemiol. 130:950-7.
3. Conde-Agudelo A, Althabe F, Belizan JM, Kafury-Goeta AC. (1999) Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. Am. J. Obstet. Gynecol. 181:1026-35.
4. Lindqvist PG, Marsal K. (1999) Moderate smoking during pregnancy is associated with a reduced risk of preeclampsia. Acta Obstet. Gynecol. Scand. 78:693-7.
5. Xiong X, Wang FL, Davidge ST, Demianczuk NN, Mayes DC, Olson DM, Saunders LD. (2000) Maternal smoking and preeclampsia. J. Reprod. Med. 45:727-32.
6. Mortensen JT, Thulstrup AM, Larsen H, Moller M, Sorensen HT. (2001) Smoking, sex of the offspring, and risk of placental abruption, placenta previa, and preeclampsia: a population-based cohort study. Acta Obstet. Gynecol. Scand. 80:894-8.
7. Sibai B, Dekker G, Kupferminc M. (2005) Preeclampsia. Lancet 365:785-99.
8. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. (2002) Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 9:147-60.
9. Levine RJ, Maynard SE, Qian C, et al. (2004) Circulating angiogenic factors and the risk of preeclampsia. N. Engl J. Med. 350:672-83.
10. McKeeman GC, Ardill JE, Caldwell CM, Hunter AJ, McClure N. (2004) Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am. J. Obstet. Gynecol 191:1240-6.
11. Bdolah Y, Karumanchi SA, Sachs BP. (2005) Recent advances in understanding of preeclampsia. Croat. Med. J. 46:728-36.
12. Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CW (1995) Interleukin-6, tumor necrosis factor and soluble tumor necrosis factor receptors in women with pre-eclampsia. Br. J. Obstet. Gynaecol. 102:20-5.
13. Chen G, Wilson R, Wang SH, Zheng HZ, Walker JJ, McKillop JH. (1996) Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia. Clin. Exp. Immunol. 104:154-9.
14. Wang Y, Walsh SW. (1996) TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas. J. Reprod. Immunol. 32:157-69.
15. Kimya Y, Akdis C, Cengiz C, Ozan H, Tatlikazan S, Uncu G, Sengul F. (1997) Plasma interleukin-1alpha, interleukin-1beta and interleukin-1 receptor antagonist levels in pre-eclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 73:17-21.
16. Velzing-Aarts FV, Muskiet FA, van der Dijs FP, Duits AJ. (2002) High serum interleukin-8 levels in afro-caribbean women with pre-eclampsia. Relations with tumor necrosis factor-alpha, duffy negative phenotype and von Willebrand factor. Am. J. Reprod. Immunol. 48:319-22.
17. Johnson MR, Anim-Nyame N, Johnson P, Sooranna SR, Steer PJ. (2002) Does endothelial cell activation occur with intrauterine growth restriction? BJOG. 109:836-9.
18. Conrad KP, Miles TM, Benyo DF. (1998) Circulating levels of immunoreactive cytokines in women with preeclampsia. Am. J. Reprod. Immunol. 40:102-11.
19. Lindstrom TM, Bennett PR. (2005) The role of nuclear factor kappa B in human labor. Reproduction 130:569-81.
20. Luppi P, Tse H, Lain KY, Markovic N, Piganelli JD, DeLoia JA. (2006) Preeclampsia activates circulating immune cells with engagement of the NF-kappaB pathway. Am. J. Reprod. Immunol. 56:135-44.
21. Gallowitsch-Puerta M, Tracey KJ. (2005) Immunologic role of the cholinergic anti-inflammatory pathway and the nicotinic acetylcholine alpha 7 receptor. Ann. N. Y. Acad. Sci. 1062:209-19.
22. Sykes AP, Brampton C, Klee S, Chander CL, Whelan C, Parsons ME. (2000) An investigation into the effect and mechanisms of action of nicotine in inflammatory bowel disease. Inflamm. Res. 49:311-9.
23. Wang H, Liao H, Ochani M, et al. (2004) Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 10:1216-21.
24. Saeed RW, Varma S, Peng-Nemeroff T, et al. (2005) Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J. Exp. Med. 201:1113-23.
25. Wang H, Yu M, Ochani M, et al. (2003) Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421:384-8.
26. Shytle RD, Mori T, Townsend K, et al. (2004) Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J. Neurochem. 89:337-43.
27. Hesse DG, Tracey KJ, Fong Y, et al. (1988) Cytokine appearance in human endotoxemia and primate bacteremia. Surg. Gynecol. Obstet. 166:147-53.
28. Simosky JK, Stevens KE, Kern WR, Freedman R. (2001) Intragastric DMXB-A, an alpha7 nicotinic agonist, improves deficient sensory inhibition in DBA/2 mice. Biol. Psychiatry 50:493-500.
29. Shimohama S, Greenwald DL, Shafron DH, et al. (1998) Nicotinic alpha 7 receptors protect against glutamate neurotoxicity and neuronal ischemic damage. Brain Res. 779:359-63.
30. O'Neill, HC, Rieger K, Kem WR, Stevens KE. (2003) DMXB, an alpha7 nicotinic agonist, normalizes auditory gating in isolation-reared rats. Psychopharmacology (Berl). 169:332-9.
31. HHS-CDC. (2004) Smoking during pregnancy - United States, 1990-2002. Morb. Mortal Wkly. Rep. 53:911-5.
32. Srinivas SK, Macones GA. (2005) Preterm premature rupture of the fetal membranes: current concepts. Minerva Ginecol. 57:389-96.
33. Tikkanen M, Nuutila M, Hiilesmaa V, Paavonen J, Ylikorkala O. (2006) Clinical presentation and risk factors of placental abruption. Acta Obstet. Gynecol. Scand. 85:700-5.
34. Usta IM, Hobeika EM, Musa AA, Gabriel GE, Nassar H. (2005) Placenta previa-accreta: risk factors and complications. Am. J. Obstet. Gynecol. 193:1045-9.
35. Salihu HM, Aliyu MH, Kirby RS. (2005) In utero nicotine exposure and fetal growth inhibition among twins. Am. J. Perinatol. 22:421-7.
36. Hunt CE, Hauck FR. (2006) Sudden infant death syndrome. CMAJ. 174:1861-9.
37. England LJ, Levine RJ, Qian C, et al. (2002) Smoking before pregnancy and risk of gestational hypertension and preeclampsia. Am. J. Obstet. Gynecol. 186:1035-40.
38. de Jonge WJ, van der Zanden EP, The FO, et al. (2005) Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat. Immunol. 6:844-51.
39. van Westerloo DJ, Giebelen IA, Florquin S, et al. (2006) The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology. 130:1822-30.
40. Green JT, Thomas GA, Rhodes J, et al. (1997) Nicotine enemas for active ulcerative colitis - a pilot study. Aliment. Pharmacol. Ther. 11:859-63.
41. Guslandi M. (1999) Long-term effects of a single course of nicotine treatment in acute ulcerative colitis: remission maintenance in a 12-month follow-up study. Int. J. Colorectal Dis. 14:261-2.
42. Hauguel-de MS, Guerre-Millo M. (2006) The placenta cytokine network and inflammatory signals. Placenta. 27:794-8.
43. Borzychowski AM, Sargent IL, Redman CW. (2006) Inflammation and pre-eclampsia. Semin. Fetal Neonatal Med. 11:309-16.
44. Redman CW, Sargent IL. (2005) Latest advances in understanding preeclampsia. Science 308:1592-4.
45. Sargent IL, Borzychowski AM, Redman CW. (2006) Immunoregulation in normal pregnancy and pre-eclampsia: an overview. Reprod. Biomed. Online 13:680-6.
46. Redman CW, Sargent IL. (2000) Placental debris, oxidative stress and pre-eclampsia. Placenta 21:597-602.
47. Redman CW, Sargent IL. (2004) Preeclampsia and the systemic inflammatory response. Semin. Nephrol. 24:565-70.
48. Matthiesen L, Berg G, Ernerudh J, Ekerfelt C, Jonsson Y, Sharma S. (2005) Immunology of preeclampsia. Chem. Immunol. Allergy 89:49-61.
49. Luppi P, DeLoia JA. (2006) Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines. Clin. Immunol. 118:268-75.
50. Feinberg BB. (2006) Preeclampsia: the death of Goliath. Am. J. Reprod. Immunol. 55:84-98.
51. Hu XL, Yang Y, Hunt JS. (1992) Differential distribution of interleukin-1 alpha and interleukin-1 beta proteins in human placentas. J. Reprod. Immunol. 22:257-68.
52. Chen HL, Yang YP, Hu XL, Yelavarthi KK, Fishback JL, Hunt JS. (1991) Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am. J. Pathol. 139:327-35.
53. Hunt JS. (1989) Cytokine networks in the utero-placental unit: macrophages as pivotal regulatory cells. J. Reprod. Immunol. 16:1-17.
54. Yelavarthi KK, Chen HL, Yang YP, Cowley BD, Fishback JL, Hunt JS. (1991) Tumor necrosis factor-alpha mRNA and protein in rat uterine and placental cells. J. Immunol. 146:3840-8.
55. Xu B, Makris A, Thornton A, Hennessy A. (2005) Glucocorticoids inhibit placental cytokines from cultured normal and preeclamptic placental explants. Placenta 26:654-60.
56. Bainbridge SA, Sidle EH, Smith GN. (2005) Direct placental effects of cigarette smoke protect women from pre-eclampsia: the specific roles of carbon monoxide and antioxidant systems in the placenta. Med. Hypotheses 64:17-27.
57. Kwon JY, Kim YH, Kim SH, Kang MH, Maeng YS, Lee KY, Park YW. (2006) Difference in the expression of alpha 7 nicotinic receptors in the placenta in normal versus severe preeclampsia pregnancies. Eur. J. Obstet. Gynecol. Reprod. Biol. 132:35-9.
58. Lips KS, Bruggmann D, Pfeil U, Vollerthun R, Grando SA, Kummer W. (2005) Nicotinic acetylcholine receptors in rat and human placenta. Placenta 26:735-46.
59. Tsatsaris V, Goffin F, Munaut C, et al. (2003) Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J. Clin. Endocrinol. Metab. 88:5555-63.
60. Maynard SE, Min JY, Merchan J, et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111:649-58.
61. Zhou Y, McMaster M, Woo K, et al. (2002) Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am. J. Pathol. 160:1405-23.
62. Rajakumar A, Michael HM, Rajakumar PA, et al. (2005) Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women. Placenta 26:563-73.
63. Clavel G, Bessis N, Lemeiter D, et al. (2007) Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction. Clin. Immunol. (epub, ahead of print).
64. Belgore FM, Lip GY, Blann AD. (2000) Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers. Br. J. Biomed. Sci. 57:207-13.
65. Mehendale R, Hibbard JFALR. (2006) Placental angiogenesis marker, hypoxia, and cigarette smoke. Am. J. Obstet. Gynecol. 195:S134.
66. Pavlov VA, Ochani M, Yang LH, et al. (2007) Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis. Crit. Care Med. 35:1139-44.
67. Altavilla D, Guarini S, Bitto A, et al. (2006) Activation of the cholinergic anti-inflammatory pathway reduces NF-kappab activation, blunts TNF-alpha production, and protects against splanchic artery occlusion shock. Shock 25:500-6.
68. Martin JN, Rose CH, Briery CM. (2006) Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am. J. Obstet. Gynecol. 195:914-34.
69. Matchaba P, Moodley J. (2004) Corticosteroids for HELLP syndrome in pregnancy. Cochrane. Database. Syst. Rev. CD002076.
70. Isler CM, Barrilleaux PS, Magann EF, Bass JD, Martin JN. (2001) A prospective, randomized trial comparing the efficacy of dexamethasone and betamethasone for the treatment of antepartum HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am. J. Obstet. Gynecol. 184:1332-7.
71. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA. (2007) Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 369:1791-8.